Clinical Trial Update: Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of gemcitabine hydrochloride and carboplatin with or without MK-0646 for first-line treatment of stage IIIB or IV non-small cell lung cancer has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• MK-0646 (dalotuzumab)
• Paraplatin (Carboplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 2 | Status: WITHDRAWN